Refractory Neoplasm

general

A neoplasm that does not respond to treatment.

41

Centers

74

Active Trials

$7.7B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Refractory Cancer41

Top Centers for Refractory Neoplasm(41)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.8
2
NCI Comprehensive
Active Research Program
53.8
3
NCI Comprehensive
Active Research Program
53.8
4
NCI Comprehensive
Active Research Program
53.8
5
NCI Comprehensive
Active Research Program
53.8
6
NCI Comprehensive
Active Research Program
53.8
7
NCI Comprehensive
Active Research Program
53.8
8
NCI Comprehensive
Active Research Program
53.8
9
NCI Comprehensive
Active Research Program
53.8
10
NCI Clinical
Active Research Program
53.8
11
NCI Comprehensive
Active Research Program
53.8
12
NCI Comprehensive
Active Research Program
53.8
13
Active Research Program
53.8
14
Active Research Program
53.8
15
Active Research Program
53.8
16
Active Research Program
53.8
17
Active Research Program
53.8
18
Active Research Program
53.8
19
NCI Comprehensive
31.3
20
NCI Comprehensive
21
NCI Comprehensive
22
23
NCI Comprehensive
24
NCI Comprehensive
25
NCI Comprehensive
26
27
28
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
29
NCI Comprehensive
30
NCI Comprehensive
31
32
NCI Comprehensive
33
34
35
Cedars-Sinai CancerLos Angeles, CA
36
NCI Comprehensive
37
38
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
39
40
NCI Comprehensive
41

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →